Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy

Clinical trial NCT01222767 · COMPLETED

Trial details

NCT number: NCT01222767
Sponsor: PharmaMar
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ewing's Sarcoma Primitive Neuroectodermal Tumor (PNET)Askin's Tumor of the Chest Wall Extraosseous Ewing's Sarcoma (EOE)

Start date: 2010-12-01
Primary completion: 2012-04-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.